NYSE:BLCOMedical Equipment
Is Bausch + Lomb’s Raised 2026 Outlook And Board Refresh Altering The Investment Case For BLCO?
Bausch + Lomb Corporation recently reported second-quarter 2026 results showing revenue of US$1.39 billion and a reduction in net loss to US$14 million, while also raising its full-year 2026 revenue guidance to a range of US$5.44 billion–US$5.54 billion.
Shortly after those results, the company reshaped its board by appointing four new directors with deep finance, healthcare and investment backgrounds to replace four resigning members, potentially influencing future oversight and capital...